← k3vl4r
Log inGet started →

PACB (Pacific Biosciences of California Inc) Price Forecast

AI-generated price forecast for Pacific Biosciences of California Inc (PACB) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

As of July 2026: K3vl4r's AI model currently reads PACB as 2/2 bullish · strong across its horizons (2 of 2 timeframes pointing up), with a last price of 1.35. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP

Last price

1.35

AI outlook

2/2 bullish · STRONG

Timeframes up

2 / 2

Share𝕏 Post✈ Telegram

PACB forecast by horizon

HorizonDirectionProjected move (end of horizon)Bullish prob.
1-hour~10 days out———
4-hour~2 months out———
Daily~5 months out▲ Up+21.25%80%
Weekly~1.9 years out▲ Up+496.76%—

Latest PACB news

From the market-news feed the forecasts are read against.

  • Here's Why Pacific Biosciences of California (PACB) Fell More Than Broader Market · Zacks · Jul 20
  • Pacific Biosciences of California (PACB) Dips More Than Broader Market: What You Should Know · Zacks · Jul 13
  • Pacific Biosciences of California (PACB) Stock Drops Despite Market Gains: Important Facts to Note · Zacks · Jul 6
  • Is Pacific Biosciences (PACB) The Best Rising Penny Stock? · Insider Monkey · Jul 3
  • 3 Cash-Burning Stocks with Questionable Fundamentals · StockStory · Jul 1

🔒

See the full PACB forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

PACB forecast — frequently asked

Will PACB go up?

K3vl4r's AI model currently reads PACB as 2/2 bullish · STRONG — 2 of 2 forecast horizons point up, so the overall read is leaning to the upside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the PACB price prediction for 2026?

K3vl4r's model projects PACB toward $1.35 over the next ~5 months, a +0.2% move from $1.35. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What price could PACB reach?

Over its longest horizon (~~1.9 years), the model's projected target for PACB is $1.42 (+5.0% vs $1.35). Confidence decreases the further out the horizon, so treat longer-range targets as one scenario, not a guarantee. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Healthcare forecasts — browse the full sector.

More AI forecasts

CNSPNAMSVORTCRXCINGAORTSHCHYPDNTRARYTMSTTKCNTXSTIMCAPR

Will PACB reach…?

Will PACB reach $2.00?Will PACB reach $3.00?Will PACB reach $5.00?Will PACB reach $10.00?

Or see the full PACB price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare PACB

PACB vs CNSPPACB vs NAMSPACB vs VORPACB vs TCRXPACB vs CINGPACB vs AORT

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

k3vl4rTop PicksTrack recordChart indicatorsToday's outlookBiggest moversMarket heatmapForecasts by sectorAI reportsCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsPricingX (Twitter)Twitch — live forecastingDiscord community

Join the community on Discord and catch live forecasting on Twitch. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.